Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCDC59 pseudogene 1 (CCDC59P1) refers to a predicted or annotated *pseudogene* of the parental gene *Coiled-Coil Domain Containing 59* (CCDC59). Pseudogenes are typically non-functional genomic sequences that resemble protein-coding genes but do not encode functional proteins due to mutations or regulatory changes[3][6]. There is no evidence for CCDC59P1 encoding a functional protein, serving as a receptor, enzyme, transporter, or a traditional pharmacological or biological target. While some pseudogenes are known to influence cellular processes (e.g., by acting as competitive endogenous RNAs or regulators of parental gene expression), there is currently no specific data linking CCDC59P1 to any molecular function, disease mechanism, or therapeutic application[3][6]. The canonical protein-coding gene CCDC59 is distinct, with known RNA-binding and nuclear localization[1][2], but CCDC59P1 itself is not an established therapeutic target or biomarker. Additional Context and Clarification: - There is potential for confusion because the parental gene CCDC59 does encode a protein (involved in RNA binding and transcriptional regulation in the nucleus[1][2]), but CCDC59P1 is a *pseudogene* and not the same as CCDC59. - The entry is possibly *incorrect or misleading as a target* in standard drug discovery or therapeutic context, since pseudogenes are not typically targeted directly by drugs or considered classical therapeutic targets. Summary of Limitations: - Little or no specific information is available about CCDC59P1 beyond annotation as a pseudogene. - If more specific structured information on disease role, biomarkers, or druggability is required, it is recommended to re-examine the query, as the primary function of CCDC59P1 is not established in the literature or major genomic databases at this time[1][3][6]. - Any suggestion of CCDC59P1 as a “target” is likely based on a confusion with the protein-coding CCDC59 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCDC59 pseudogene 1 (CCDC59P1).